You are here

AusPAR: Trastuzumab

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

20 March 2020
AusPAR Details
AusPAR
Active Ingredient
Trastuzumab
Product Name
Ogivri
Sponsor
Alphapharm Pty Ltd
Submission Number
PM-2017-01084-1-4
Submission Type
Biosimilar
Decision
Approved
AusPAR Date
18 March 2020
Publication Date

20 March 2020